Entrada Therapeutics | Financial Information

SEC Filings

SEC Filings
Filing date	Form	Description	Filing Group	View
Oct 19, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001689375-23-000069.pdf 0001689375-23-000069.rtf 0001689375-23-000069.xls
Sep 29, 2023	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	View HTML 0001104659-23-105348.pdf 0001104659-23-105348.rtf 0001104659-23-105348.xls
Sep 29, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001104659-23-105351.pdf 0001104659-23-105351.rtf 0001104659-23-105351.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 21, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001689375-23-000068.pdf 0001689375-23-000068.rtf 0001689375-23-000068.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 15, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001689375-23-000066.pdf 0001689375-23-000066.rtf 0001689375-23-000066.xls